Triethylene Glycol

Triethylene Glycol

SCHEMBL273639

CC(=O)O.CCCOCCC.OCCOCCOCCO

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Triethylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
TSHR P16473 3/20 0.52
THRB P10828 2/20 0.52
HTT P42858 1/20 0.52
MAPT P10636 1/20 0.52
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 4/20 0.46
ACHE P22303 1/20 0.35
LMNA P02545 2/20 0.35
USP2 O75604 1/20 0.35
CYP3A4 P08684 1/20 0.35
CASP1 P29466 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLCO1B3 Q9NPD5 1/20 0.35
SLCO1B1 Q9Y6L6 1/20 0.35
HSD17B10 Q99714 1/20 0.34
CES2 O00748 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
EPHX2 P34913 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL28096518 1.00 MEN1 (0.52) MEN1KMT2ATSHRTHRBHTT
Acetic Acid SCHEMBL26934034 0.98 TSHR (0.54) MEN1KMT2ATSHRTHRBHTT
Di(Hydroxyethyl)Ether SCHEMBL27602727 0.98 TSHR (0.54) MEN1KMT2ATSHRTHRBHTT
Acetic Acid SCHEMBL896476 0.90 TSHR (0.44) MEN1KMT2ATSHRTHRBHTT
Triethylene Glycol SCHEMBL994880 0.90 MEN1 (0.65) MEN1KMT2ATSHRTHRBHTT
Tetraethylene Glycol SCHEMBL28411928 0.90 MEN1 (0.65) MEN1KMT2ATSHRTHRBHTT
Acetic Acid SCHEMBL21878939 0.90 MEN1 (0.65) MEN1KMT2ATSHRTHRBHTT
Triethylene Glycol SCHEMBL7049732 0.90 MEN1 (0.65) MEN1KMT2ATSHRTHRBHTT
Acetic Acid SCHEMBL21878891 0.90 MEN1 (0.65) MEN1KMT2ATSHRTHRBHTT
Pentaethylene Glycol SCHEMBL9614725 0.90 MEN1 (0.65) MEN1KMT2ATSHRTHRBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125594-A1 QUANTUM DOT-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-05-07 US disclosed
WO-2025088985-A1 QUANTUM DOT BODY, QUANTUM DOT COMPOSITION, AND WAVELENGTH CONVERSION MATERIAL AND PRODUCTION METHOD THEREOF 信越化学工業株式会社 2025-05-01 WO disclosed
WO-2024241965-A1 QUANTUM DOT-CONTAINING COMPOSITION, WAVELENGTH CONVERSION MEMBER, AND METHOD FOR PRODUCING QUANTUM DOT-CONTAINING COMPOSITION 信越化学工業株式会社 2024-11-28 WO disclosed
CN-116891654-B Inkjet ink composition and recording method 精工爱普生株式会社 2024-11-08 CN disclosed
WO-2024135284-A1 QUANTUM-DOT-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, AND WAVELENGTH CONVERSION MEMBER 信越化学工業株式会社 2024-06-27 WO disclosed
US-11999180-B2 Recording method and recording device SEIKO EPSON CORPORATION (JP) 2024-06-04 US disclosed
WO-2024043081-A1 INK COMPOSITION, PRODUCTION METHOD FOR INK COMPOSITION, AND PRODUCTION METHOD FOR COLOR FILTER 信越化学工業株式会社 2024-02-29 WO disclosed
CN-116891654-A Inkjet ink composition and recording method 精工爱普生株式会社 2023-10-17 CN disclosed
US-20230312959-A1 Ink Jet Ink Composition And Recording Method SEIKO EPSON CORPORATION (JP) 2023-10-05 US disclosed
US-11465420-B2 Ink jet ink set and printing method SEIKO EPSON CORPORATION 2022-10-11 US disclosed
US-20050241532-A1 Organic formulations of pigment LANXESS DEUTSCHLAND GMBH (DE) 2005-11-03 US disclosed
US-20050131091-A1 Process for producing synthetic resin foam, blowing agent and premix DAIKIN INDUSTRIES, LTD. (JP) 2005-06-16 US disclosed
US-20050043422-A1 Process for producing synthetic resin foam DAIKIN INDUSTRIES, LTD. (JP) 2005-02-24 US disclosed
US-6849385-B2 Photosensitive resin composition, process of forming patterns with the same, and electronic components HITACHI CHEMICAL CO., LTD. (JP) 2005-02-01 US disclosed
EP-1498439-A1 PROCESS FOR PRODUCING SYNTHETIC RESIN FOAM, BLOWING AGENT, AND PREMIX Daikin Industries, Ltd. (JP) 2005-01-19 EP disclosed
US-20040180286-A1 Photosensitive resin composition, process of forming patterns with the same, and electronic components HITACHI CHEMICAL CO., LTD. (JP) 2004-09-16 US disclosed
EP-1457506-A1 PROCESS FOR PRODUCING SYNTHETIC RESIN FOAM Daikin Industries, Ltd. (JP) 2004-09-15 EP disclosed
CN-1522388-A Photosensitive resin composition, method for producing pattern and electronic parts 日立化成工业株式会社 2004-08-18 CN disclosed
US-6596446-B2 Used in in printing inks BAYER AKTIENGESELLSCHAFT (DE) 2003-07-22 US disclosed
US-20020034696-A1 Organic pigments in color filters of liquid crystal display LANXESS DEUTSCHLAND GMBH (DE) 2002-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125594-A1 QUANTUM DOT-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME ITGA6, STRA6, ILK MEN1 4558/4885KMT2A 1830/4885TSHR 1369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.